Dynamic Metabolic Imaging of Hyperpolarized Substrates
Dynamic Metabolic Imaging of Hyperpolarized Substrates
批准号:
8750998
负责人:
Dirk Mayer
金额:
$14.72万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2014-09-30
中文摘要
描述(由申请人提供):超极化磁共振成像(MRI)试剂的开发,即,MRI可见化合物的磁化强度远高于体内温度下通常达到的磁化强度,这既带来了前所未有的机遇,也带来了新的技术挑战。特别是,随着信噪比(SNR)增强约10,000倍,代谢活性底物的动态核极化(DNP)理论上允许注射剂和下游代谢产物的高分辨率体内化学位移成像(CSI),提供了一种独特的方法来评估动态代谢过程。最近的研究表明,无氧和有氧代谢可以在体内进行研究后,超极化的13 C1-丙酮酸的推注,和应用包括肿瘤诊断和监测,心血管病理学的研究,和代谢紊乱的评价。虽然,可靠的,经过充分验证的方法是成功应用超极化CSI在体内代谢的研究,优化的数据采集和分析工具尚未开发的关键。这项为期4年的技术开发项目旨在通过实施高速体积CSI技术(目标1)以及稳健的动力学建模算法(目标2)来显著增强这项新技术,以定量评估体内数据。将优化所得工具,用于在动物模型中对超极化底物进行成像,并在模拟、体模和体内啮齿动物模型中评价最终采集方法和数据分析算法(目标3)。虽然这项建议的重点是成像超极化13 C-丙酮酸及其下游代谢产物,大部分的工作将同样适用于其他代理,因为他们的发展。这些目标的成功完成将提供必要的定量工具,以允许在正常和病理条件下的代谢的直接成像,疾病过程的纵向监测,以及治疗干预措施的早期评估。考虑到该技术的非侵入性性质,预计这种新的代谢成像能力将在未来3-5年内从实验室转移到临床,第一次使用超极化丙酮酸盐评估前列腺癌的人体试验计划于2009年进行。
英文摘要
DESCRIPTION (provided by applicant): The development of hyperpolarized magnetic resonance imaging (MRI) agents, i.e., MRI-visible compounds whose magnetization is much higher than that normally achieved at in vivo temperatures, presents both unprecedented opportunities as well as new technical challenges. In particular, with signal-to-noise ratio (SNR) enhancements on the order of the 10,000-fold, dynamic nuclear polarization (DNP) of metabolically active substrates theoretically permits high-resolution in vivo chemical shift imaging (CSI) of both the injected agent and downstream metabolic products, providing a unique method to assess dynamic metabolic processes. Recent studies have demonstrated that both anaerobic and aerobic metabolism can be studied in vivo following the bolus injection of hyperpolarized 13C1-pyruvate, and applications include tumor diagnosis and monitoring, the study of cardiovascular pathologies, and the evaluation of metabolic disorders. Although, reliable, well-validated methods are critical for the successful application of hyperpolarized CSI to the study of in vivo metabolism, optimized data acquisition and analysis tools have yet to be developed. This 4- year technical development project proposes to significantly enhance this new technology through the implementation of high-speed volumetric CSI techniques (Aim 1) in conjunction with robust kinetic modeling algorithms (Aim 2) for the quantitative evaluation of in vivo data. The resulting tools will be optimized for imaging hyperpolarized substrates in animal models with the final acquisition methods and data analysis algorithms evaluated in simulations, phantoms, and in vivo rodent models (Aim 3). Although this proposal is focused on imaging hyperpolarized 13C-pyruvate and its downstream metabolic products, much of the work will be equally applicable to other agents as they are developed. The successful completion of these goals will provide the quantitative tools necessary to allow the direct imaging of metabolism in normal and pathologic conditions, the longitudinal monitoring of disease processes, and the early evaluation of therapeutic interventions. Given the noninvasive nature of the technology, translation of this new metabolic imaging capability from the laboratory to the clinic is anticipated occur within the next 3-5 years, with the first human trial using hyperpolarized pyruvate for the evaluation of prostate cancer scheduled for 2009.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Dynamic metabolic imaging of copolarized [2-13 C]pyruvate and [1,4-13 C2 ]fumarate using 3D-spiral CSI with alternate spectral band excitation.
使用具有交替光谱带激发的 3D 螺旋 CSI 对共极化 [2-13 C] 丙酮酸盐和 [1,4-13 C2 ] 富马酸盐进行动态代谢成像。
DOI:
10.1002/mrm.27639
发表时间:
2019
期刊:
Magnetic resonance in medicine
影响因子:
3.3
作者:
[Singh,Maninder, Josan,Sonal, Zhu,Minjie, Jhajharia,Aditya, Mayer,Dirk]
通讯作者:
Mayer,Dirk
DOI:
10.1002/mrm.26170
发表时间:
2017-03
期刊:
Magnetic resonance in medicine
影响因子:
3.3
作者:
[DeVience SJ, Mayer D]
通讯作者:
Mayer D
Metabolic imaging of hyperpolarized 13C pyruvate in polycystic kidney disease
-
批准号:10527162
-
项目类别:
-
资助金额:$11.77万
-
财政年份:2022
-
负责人:Dirk Mayer
-
依托单位:
Metabolic imaging of energy metabolism in traumatic brain injury using hyperpolarized 13C pyruvate
-
批准号:9092692
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2016
-
负责人:Dirk Mayer
-
依托单位:
Dynamic Metabolic Imaging of Hyperpolarized Substrates
-
批准号:8212418
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2009
-
负责人:Dirk Mayer
-
依托单位:
Dynamic Metabolic Imaging of Hyperpolarized Substrates
-
批准号:7662585
-
项目类别:
-
资助金额:$39.66万
-
财政年份:2009
-
负责人:Dirk Mayer
-
依托单位:
Dynamic Metabolic Imaging of Hyperpolarized Substrates
-
批准号:7783802
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2009
-
负责人:Dirk Mayer
-
依托单位:
Dynamic Metabolic Imaging of Hyperpolarized Substrates
-
批准号:8013940
-
项目类别:
-
资助金额:$38.33万
-
财政年份:2009
-
负责人:Dirk Mayer
-
依托单位:
国内基金
海外基金
丝氨酸/甘氨酸/一碳代谢网络(SGOC metabolic network)调控炎症性巨噬细胞活化及脓毒症病理发生的机制研究
-
批准号:81930042
-
项目类别:重点项目
-
资助金额:305.0万元
-
批准年份:2019
-
负责人:王迪
-
依托单位: